Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | RTW Biotech Opportunities Ltd (Ordinary Share) | +28.70% |
NAV | RTW Biotech Opportunities Ltd (Ordinary Share) | +31.97% |
Morningstar's Benchmark | Russell 2000 Biotech Growth [50.00%]; Nasdaq Biotechnology Index [50.00%] | -- |
Events & Activity
Key statistics
On Friday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 1.48, -14.45% below its 52-week high of 1.73, set on Jul 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 335.71m |
---|---|
Market cap | 496.86m USD |
Total assets | 651.28m USD |
Total expense ratio | 1.97% |
High | 1.48 |
Low | 1.46 |
Previous close | 1.48 |
Average volume | 750.45k |
---|---|
YTD Change | +5.53% |
Beta | 0.6435 |
Diluted NAV (est) | 1.94 |
Diluted NAV (last pub) | 1.94 |
Premium/Discount | -23.71% |
Net Gearing | 0.00% |
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.
More ▼